Abbott Groupe: The latest figures, news and market research on Abbott Groupe

Turnover: 43.7 billion USD (2022)

Country: United States

Group of over 100,000 people

Abbott is an American pharmaceutical group based in Chicago and founded by Wallace Calvin Abbott. The group is present in 163 countries.

A pioneer and leader in the pharmaceutical industry, Abbott created the first HIV test in 1985. The group spends several billion on research and development every year.

It operates in the cardiovascular, diabetes, medical diagnostics, neuromulation and nutrition markets.

Its subsidiary Abbott Nutrition is one of the leading producers of infant milk in the USA

News

Abbott: improvement and investment 20/06/2023

Abbott generates around 60% of its sales outside the United States
The company achieved sales of $43.6 billion in 2022
The company acquired St. Jude Medical in 2017 for $25 billion

Abbott Nutrition relaunches baby milk powder production 04/06/2022

Abbott Nutrition is one of four companies that account for approximately 90% of baby milk powder production in the United States, including Reckitt and Gerber

Abbott acquires St. Jude for $25 billion 28/04/2018

Abbott Laboratories bought St. Jude Medical for $25 billion (€22.03 billion).
Abbott must also finance the planned acquisition of Alere, announced in February for $5.8 billion.
Abbott plans to refinance St. Jude's net debt of around $5.7 billion.
Following the acquisition, Abbott's cardiovascular devices business will have sales of $8.7 billion, placing the group in a leading position in this market.

Financial Data

DUNS: 602950206

Legal Name: ABBOTT FRANCE

Address: 3 PL GUSTAVE EIFFEL BATIMENT FLORENCE, 94150 RUNGIS

Number of employees: Entre 250 et 499 salariés (2017)

Capital: 100 685 231

Financial Data:

Year	Turnover (€)	Net Profit (€)	Fiscal Year End	Fiscal Year Duration
2019	387 518 103 EUR	6 621 050 EUR	31/12/2019	12
2018	474 574 415 EUR	10 924 390 EUR	31/12/2018	12
2017	362 481 566 EUR	10 968 533 EUR	31/12/2017	12
2016	293 844 924 EUR	7 514 064 EUR	31/12/2016	12
2015	289 222 819 EUR	7 608 056 EUR	31/12/2015	12